A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with carboplatin and etoposide in extensive stage small cell lung cancer Article

cited authors

  • Gillenwater, HH; McCune, JS; Lindley, C; Faucette, S; Shord, S; Donahue, A; Socinski, MA; Stewart, CF; Zamboni, WC; Kirstein, MN; Moore, D

authors

Publication Date

  • January 1, 2005

webpage

published in

category

keywords

  • MTSE
  • carboplatin
  • etoposide
  • extensive stage
  • small cell lung cancer
  • topotecan

start page

  • 511

end page

  • 519

volume

  • 23

issue

  • 6